226 related articles for article (PubMed ID: 9443307)
21. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
Eber E; Zach MS
Thorax; 2010 Oct; 65(10):849-51. PubMed ID: 20861286
[No Abstract] [Full Text] [Related]
22. Editorial: Pseudomonas vaccines.
Lancet; 1975 Jul; 2(7926):168. PubMed ID: 49756
[No Abstract] [Full Text] [Related]
23. Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
Lang AB; Horn MP; Imboden MA; Zuercher AW
Vaccine; 2004 Dec; 22 Suppl 1():S44-8. PubMed ID: 15576201
[TBL] [Abstract][Full Text] [Related]
24. Clinical use of monovalent vaccines in the treatment of Pseudomonas aeruginosa infection.
De Fajardo CL; Delfino AH; Laborde HF
Prog Immunobiol Stand; 1971; 5():425-7. PubMed ID: 4633970
[No Abstract] [Full Text] [Related]
25. Cystic fibrosis and pseudomonas infection.
Lancet; 1983 Jul; 2(8344):257-8. PubMed ID: 6135081
[No Abstract] [Full Text] [Related]
26. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
Lahiri T
Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
[TBL] [Abstract][Full Text] [Related]
27. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
Meitert E; Meitert T; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
[No Abstract] [Full Text] [Related]
28. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
Joó I; Stanislavskii ES
J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
[TBL] [Abstract][Full Text] [Related]
29. [Investigations on the immunogenicity of Pseudomonas seruginosa strains of different serological O-groups].
Meitert E; Meitert T
Zentralbl Bakteriol Orig; 1968; 208(4):515-21. PubMed ID: 5000090
[No Abstract] [Full Text] [Related]
30. Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.
Pennington JE
J Infect Dis; 1974 Nov; 130 Suppl(0):S159-62. PubMed ID: 4213986
[No Abstract] [Full Text] [Related]
31. Anti-Pseudomonas immunoglobulin. IV. Combined anti-Pseudomonas immunoglobulin and Pseudomonas vaccine immunotherapy of burned patients--clinical investigations.
Sakiel S; Schiller B; Buchowicz I; Lysakowska E; Tomanek E; Kruczałowa M; Przewdziecka M
Arch Immunol Ther Exp (Warsz); 1984; 32(5):523-8. PubMed ID: 6534319
[TBL] [Abstract][Full Text] [Related]
32. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
Lieberman MM; Walker HL; Ayala E; Chapa I
J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K
J Pediatr; 2001 May; 138(5):699-704. PubMed ID: 11343046
[TBL] [Abstract][Full Text] [Related]
35. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
Pennington JE; Pier GB; Sadoff JC; Small GJ
Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
[TBL] [Abstract][Full Text] [Related]
36. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
Roe EA; Jones RJ
Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
Schaad UB; Lang AB; Wedgwood J; Ruedeberg A; Que JU; Fürer E; Cryz SJ
Lancet; 1991 Nov; 338(8777):1236-7. PubMed ID: 1682645
[TBL] [Abstract][Full Text] [Related]
38. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Ratjen F
Curr Opin Pulm Med; 2006 Nov; 12(6):428-32. PubMed ID: 17053493
[TBL] [Abstract][Full Text] [Related]
39. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
Griese M; Müller I; Reinhardt D
Eur J Med Res; 2002 Feb; 7(2):79-80. PubMed ID: 11891148
[TBL] [Abstract][Full Text] [Related]
40. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?
Høiby N; Johansen HK
J Hosp Infect; 2007 Apr; 65(4):374-5; author reply 375-6. PubMed ID: 17275952
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
